SEOUL, Jan. 31 (Korea Bizwire) — Celltrion Inc., a major South Korean biopharmaceutical firm, said Friday its new biosimilar for an autoimmune disease treatment has received approval from the U.S.

The price to buy certain infused biosimilars can be three times higher than reimbursement, and the problem is growing.

CGI , one of the largest independent IT and business consulting services firms in the world, today announced that its wholly-owned limited partnership, ...

SB5, an adalimumab biosimilar approved in the US, is showing to be safe and effective for patients with psoriasis in the long term, according to a study from the UK and Ireland.